Clinical Trials Browser

Phase 1/2 × defactinib × CNS × Clear all

NCT06630260 2026-01-21

5G-RUBY

Phase 1/2 Recruiting

Glioblastoma

NCT06194929 2025-12-03

DETERMINE

Phase 1/2 Recruiting

CNSDermatologic

Brain Neoplasms, Melanoma